Cargando…
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
Present anti-PD and -AD drugs have limited symptomatic activity and devoid of neuroprotective and neurorestorative property that is needed for disease modifying action. The complex pathology of PD and AD led us to develop several multi-target neuroprotective and neurorestorative drugs with several C...
Autor principal: | Youdim, Moussa B.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620452/ https://www.ncbi.nlm.nih.gov/pubmed/23585716 http://dx.doi.org/10.5607/en.2013.22.1.1 |
Ejemplares similares
-
Why Do We Need Multifunctional Neuroprotective and Neurorestorative
Drugs for Parkinson’s and Alzheimer’s Disorders?
por: Youdim, Moussa B. H.
Publicado: (2010) -
Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
por: Youdim, Moussa B. H.
Publicado: (2010) -
Promise of Neurorestoration and Mitochondrial Biogenesis in Parkinson's Disease with Multi Target Drugs: An Alternative to Stem Cell Therapy
por: Youdim, Moussa BH, et al.
Publicado: (2013) -
Neuroprotective and neurorestorative potential of xenon
por: Lavaur, J, et al.
Publicado: (2016) -
Stem Cell-Based Neuroprotective and Neurorestorative Strategies
por: Hung, Chia-Wei, et al.
Publicado: (2010)